PT  - JOURNAL ARTICLE
AU  - Tatiana Melnikova
AU  - Susan Fromholt
AU  - HyunSu Kim
AU  - Deidre Lee
AU  - Guilian Xu
AU  - Ashleigh Price
AU  - Brenda D. Moore
AU  - Todd E. Golde
AU  - Kevin M. Felsenstein
AU  - Alena Savonenko
AU  - David R. Borchelt
TI  - Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis
AID  - 10.1523/JNEUROSCI.4251-12.2013
DP  - 2013 Feb 27
TA  - The Journal of Neuroscience
PG  - 3765--3779
VI  - 33
IP  - 9
4099  - http://www.jneurosci.org/content/33/9/3765.short
4100  - http://www.jneurosci.org/content/33/9/3765.full
SO  - J. Neurosci.2013 Feb 27; 33
AB  - Transgenic mice that express mutant amyloid precursor protein (APPsi) using tet-Off vector systems provide an alternative model for assessing short- and long-term effects of Aβ-targeting therapies on phenotypes related to the deposition of Alzheimer-type amyloid. Here we use such a model, termed APPsi:tTA, to determine what phenotypes persist in mice with high amyloid burden after new production of APP/Aβ has been suppressed. We find that 12- to 13-month-old APPsi:tTA mice are impaired in cognitive tasks that assess short- and long-term memories. Acutely suppressing new APPsi/Aβ production produced highly significant improvements in performing short-term spatial memory tasks, which upon continued suppression translated to superior performance in more demanding tasks that assess long-term spatial memory and working memory. Deficits in episodic-like memory and cognitive flexibility, however, were more persistent. Arresting mutant APPsi production caused a rapid decline in the brain levels of soluble APP ectodomains, full-length APP, and APP C-terminal fragments. As expected, amyloid deposits persisted after new APP/Aβ production was inhibited, whereas, unexpectedly, we detected persistent pools of solubilizable, relatively mobile, Aβ42. Additionally, we observed persistent levels of Aβ-immunoreactive entities that were of a size consistent with SDS-resistant oligomeric assemblies. Thus, in this model with significant amyloid pathology, a rapid amelioration of cognitive deficits was observed despite persistent levels of oligomeric Aβ assemblies and low, but detectable solubilizable Aβ42 peptides. These findings implicate complex relationships between accumulating Aβ and activities of APP, soluble APP ectodomains, and/or APP C-terminal fragments in mediating cognitive deficits in this model of amyloidosis.